English  |  Español
POLARIS Type 1 Diabetes Clinical Study

What to expect

What does participation look like?

Learn more about Polaris T1D clinical study button

After confirming eligibility, participants who qualify for the POLARIS Study are enrolled.
Participants are followed for up to 1.5 years after receiving a single dose of GNTI-122.

How the POLARIS Type 1 Diabetes Clinical Study works -graphic

Participant Experience

Study procedures may include:

  • Screening assessments
  • Administration of GNTI-122 (single dose)
  • Follow up visits for safety


Before enrolling, the study team will explain in detail what participants can expect during the study.

All tests and procedures are of no cost to you, and you will be compensated for your time and travel.




X